Resistance to ErbB2 Tyrosine Kinase Inhibitors in Breast Cancer Is Mediated by Calcium-Dependent Activation of RelA
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-09-1041
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2010
Authors
Publisher
American Association for Cancer Research (AACR)